Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Werremeyer

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Psychiatric Services (Washington, D.C.)|May 3, 2022
Improving Community Pharmacist-Delivered Care for Patients With Psychiatric Disorders Filling an Opioid PrescriptionAmy Werremeyer, Oliver Frenzel, Mark A Strand, et al.
Innovations in Pharmacy|May 19, 2021
Examining Attitudes and Beliefs that Inhibit Pharmacist Implementation of a Statewide Opioid Harm Reduction ProgramOliver C Frenzel, Heidi Eukel, Elizabeth Skoy, et al.
The Mental Health Clinician|May 18, 2022
Positioning psychiatric pharmacists to improve mental health careJulie A Dopheide, Amy Werremeyer, Robert J Haight, et al.
Journal of Psychosocial Nursing and Mental Health Services|November 14, 2015
Use of the 9-Item Patient Health Questionnaire for Depression Assessment in Primary Care Patients With Type 2 DiabetesRobert J Willborn, Mykell Barnacle, Brody Maack, et al.
Preventing Chronic Disease|July 14, 2022
Evaluation of a Program to Screen Patients in Community Pharmacies for Opioid Misuse and Accidental OverdoseElizabeth Skoy, Oliver Frenzel, Heidi Eukel, et al.
Currents in Pharmacy Teaching & Learning|June 20, 2019
A PharmD program curricular approach to addressing the opioid crisisAmy Werremeyer, Elizabeth Skoy, Marketa Marvanova, et al.
Research in Social & Administrative Pharmacy : RSAP|August 8, 2022
Opioid risk stratification in the community pharmacy: The utility of the Opioid Risk ToolMark A Strand, Heidi N Eukel, Oliver Frenzel, et al.
Journal of the American Pharmacists Association : Japha|December 26, 2021
Opioid risk screening: Program evaluation from the community pharmacists' perspectiveOliver Frenzel, Heidi Eukel, Emily Lothspeich, et al.
Substance Abuse|March 22, 2021
Pharmacists' stigma toward patients engaged in opioid misuse: When "social distance" does not mean disease preventionAmy Werremeyer, Sydney Mosher, Heidi Eukel, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|February 9, 2023
A Longitudinal Comparison of Pharmacy Documentation Platforms Using the Technology Acceptance Model: Experiences With Opioid Risk ScreeningOliver C Frenzel, Mark Strand, Allison Welsh, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Psychiatric Services (Washington, D.C.)|May 3, 2022
Improving Community Pharmacist-Delivered Care for Patients With Psychiatric Disorders Filling an Opioid PrescriptionAmy Werremeyer, Oliver Frenzel, Mark A Strand, et al.
Innovations in Pharmacy|May 19, 2021
Examining Attitudes and Beliefs that Inhibit Pharmacist Implementation of a Statewide Opioid Harm Reduction ProgramOliver C Frenzel, Heidi Eukel, Elizabeth Skoy, et al.
The Mental Health Clinician|May 18, 2022
Positioning psychiatric pharmacists to improve mental health careJulie A Dopheide, Amy Werremeyer, Robert J Haight, et al.
Journal of Psychosocial Nursing and Mental Health Services|November 14, 2015
Use of the 9-Item Patient Health Questionnaire for Depression Assessment in Primary Care Patients With Type 2 DiabetesRobert J Willborn, Mykell Barnacle, Brody Maack, et al.
Preventing Chronic Disease|July 14, 2022
Evaluation of a Program to Screen Patients in Community Pharmacies for Opioid Misuse and Accidental OverdoseElizabeth Skoy, Oliver Frenzel, Heidi Eukel, et al.
Currents in Pharmacy Teaching & Learning|June 20, 2019
A PharmD program curricular approach to addressing the opioid crisisAmy Werremeyer, Elizabeth Skoy, Marketa Marvanova, et al.
Research in Social & Administrative Pharmacy : RSAP|August 8, 2022
Opioid risk stratification in the community pharmacy: The utility of the Opioid Risk ToolMark A Strand, Heidi N Eukel, Oliver Frenzel, et al.
Journal of the American Pharmacists Association : Japha|December 26, 2021
Opioid risk screening: Program evaluation from the community pharmacists' perspectiveOliver Frenzel, Heidi Eukel, Emily Lothspeich, et al.
Substance Abuse|March 22, 2021
Pharmacists' stigma toward patients engaged in opioid misuse: When "social distance" does not mean disease preventionAmy Werremeyer, Sydney Mosher, Heidi Eukel, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|February 9, 2023
A Longitudinal Comparison of Pharmacy Documentation Platforms Using the Technology Acceptance Model: Experiences With Opioid Risk ScreeningOliver C Frenzel, Mark Strand, Allison Welsh, et al.
Pageof 4